Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 19, 19:50
492.00
-0.15 (-0.03%)
VOLUME 13,321
LIVE
NSE
Oct 19, 19:49
490.75
-0.7 (-0.14%)
VOLUME 78,195
News on Cadila Healthcare
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cadila Healthcare up 1% on USFDA final approval for Allopurinol tablets

9.23 am | 16 Oct 2017 |  Source: Moneycontrol.com

Zydus Cadila has received final approval from the USFDA to market Allopurinol Tablets USP, 100 mg and 300 mg....

Zydus receives final approval from USFDA for Allopurinol tablets USP

6.35 pm | 14 Oct 2017 |  Source: Moneycontrol.com

Zydus receives final approval from the USFDA for Allopurinol Tablets USP...

Nifty likely to open flat; 4 top stocks to buy for maximum returns: Prakash Gaba 

8.02 am | 13 Oct 2017 |  Source: Moneycontrol.com

According to Technical Analyst Prakash Gaba of prakashgaba.com, 10,000 has now become a crucial support to work with and the next logical technical ta...

Cadila Healthcare gains 2% on USFDA nod for Desvenlafaxine tablets

1.34 pm | 12 Oct 2017 |  Source: Moneycontrol.com

The drug is used to treat major depression and will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad....

Zydus receives final approval from USFDA for Desvenlafaxine extended-release tablets

1.20 pm | 12 Oct 2017 |  Source: Moneycontrol.com

Zydus Cadila has received final approval from the USFDA to market Desvenlafaxine extended-release tablets, 50 mg and 100 mg....

5 things to expect from Q2 earnings of drug makers

2.52 pm | 10 Oct 2017 |  Source: Moneycontrol.com

Cadila Healthcare, Dr.Reddy’s, Aurobindo are the companies to watch out for with half of their revenues coming from US....

Cadila Healthcare rises 1% on USFDA nod for Amitriptyline Hydrochloride tablets

9.22 am | 09 Oct 2017 |  Source: Moneycontrol.com

The drug is used to treat depression and will be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad....

Zydus receives final approval from USFDA for Amitriptyline Hydrochloride Tablets USP

9.07 pm | 08 Oct 2017 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Amitriptyline Hydrochloride Tablets USP....

Want to significantly expand emerging market business: Cadila 

2.36 pm | 05 Oct 2017 |  Source: CNBC-TV18

In a rare television appearance, Cadila Healthcare's relatively new Managing Director, Sharvil Patel spoke with CNBC-TV18's Ekta Batra on a wh...

Zydus gets USFDA nod for overactive bladder drug

1.50 pm | 05 Oct 2017 |  Source: PTI

The company has received approval from the US Food and Drug Administration (USFDA) to market the fesoterodine fumarate extended release capsules in st...

Zydus receives final approval from USFDA for Desmopressin Nasal Spray Solution USP

1.51 pm | 04 Oct 2017 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Desmopressin Nasal Spray Solution USP, 10mcg/0.1 mL per spray, 5ml bottle....

Buy Cadila Healthcare; target of Rs 506: Geojit Research

4.18 pm | 03 Oct 2017 |  Source: Moneycontrol.com

Geojit Research is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 506 in its research report dated Sep...

Zydus receives final approval from USFDA for Doxycycline for Injection USP

4.28 pm | 02 Oct 2017 |  Source: Moneycontrol.com

Zydus Cadila has received final approval from the USFDA to market Doxycycline for injection USP, 100 mg per vial and 200 mg per vial....

Zydus Cadila gets final nod from USFDA for anti-bacteria drug

1.52 pm | 29 Sep 2017 |  Source: PTI

The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 50 mg, 75 mg, 100 mg and 150 mg,...

Cadila Healthcare gains 2% on approval from USFDA for tetracycline antibiotic

1.25 pm | 29 Sep 2017 |  Source: Moneycontrol.com

Cadila Healthcare gets approval from the US health regulator for tetracycline antibiotic....

Zydus gets USFDA nod for anti-inflammatory drug

12.50 pm | 27 Sep 2017 |  Source: PTI

The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 75 mg, it said in a BSE filin...

Cadila Healthcare falls over 3% on ratings downgrade to ‘reduce’

10.43 am | 25 Sep 2017 |  Source: Moneycontrol.com

IIFL observed that the stock has already priced in upside from big launches and valuations are also on the higher side....

Zydus receives final approval from USFDA for Amlodipine and Olmesartan Medoxomil tablets

7.33 pm | 23 Sep 2017 |  Source: Moneycontrol.com

Zydus Cadila has received final approval from the USFDA to market Amlodipine and Olmesartan Medoxomil tablets in strengths of 5mg/20mg, 5mg/40mg, 10mg...

Cadila Healthcare up 4% on USFDA approval for Itraconazole capsules

3.32 pm | 21 Sep 2017 |  Source: Moneycontrol.com

Zydus Cadila has received the final approval from the USFDA to market Itraconazole capsules, 100mg....

Zydus receives final approval from USFDA for Itraconazole Capsules

3.29 pm | 21 Sep 2017 |  Source: Moneycontrol.com

Zydus Cadial has received the final approval from the USFDA to market Itraconazole capsules, 100mg....

1 2 3 4 5
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.